AbCellera settles patent litigation with Bruker over microfluidic device tech
Bruker Corp. (BRKR) will pay AbCellera Biologics (ABCL) $36M plus future royalty payments on the former's Beacon Optofluidic platform products as part of a patent settlement. The patent in question, No. 10,087,408 owned by AbCellera, deals with microfluidic...
Seeking Alpha